Kiely John 4
4 · Amneal Pharmaceuticals, Inc. · Filed May 11, 2023
Insider Transaction Report
Form 4
Kiely John
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2023-05-10+80,128→ 179,274 total - Award
Restricted Stock Units
2023-05-09+76,453→ 76,453 total→ Class A Common Stock (76,453 underlying) - Exercise/Conversion
Restricted Stock Units
2023-05-10−80,128→ 0 total→ Class A Common Stock (80,128 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023.